Noah Goldfarb

893 total citations
38 papers, 152 citations indexed

About

Noah Goldfarb is a scholar working on Dermatology, Epidemiology and Surgery. According to data from OpenAlex, Noah Goldfarb has authored 38 papers receiving a total of 152 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Dermatology, 16 papers in Epidemiology and 12 papers in Surgery. Recurrent topics in Noah Goldfarb's work include Hidradenitis Suppurativa and Treatments (14 papers), Colorectal and Anal Carcinomas (10 papers) and Autoimmune Bullous Skin Diseases (5 papers). Noah Goldfarb is often cited by papers focused on Hidradenitis Suppurativa and Treatments (14 papers), Colorectal and Anal Carcinomas (10 papers) and Autoimmune Bullous Skin Diseases (5 papers). Noah Goldfarb collaborates with scholars based in United States, Canada and Germany. Noah Goldfarb's co-authors include Michelle A. Lowes, Afsáneh Alavi, Joslyn S. Kirby, Melissa Butt, Ronda S. Farah, Christos C. Zouboulis, Gregor B. E. Jemec, Erin M. Warshaw, John W. Frew and Vincent Piguet and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American Academy of Dermatology and British Journal of Dermatology.

In The Last Decade

Noah Goldfarb

24 papers receiving 150 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Noah Goldfarb United States 7 112 85 45 11 10 38 152
Victoria R. Barrio United States 7 49 0.4× 27 0.3× 27 0.6× 6 0.5× 15 1.5× 15 123
Jane Woods Australia 10 196 1.8× 132 1.6× 75 1.7× 5 0.5× 21 2.1× 19 255
Yiqiu Yao Denmark 12 254 2.3× 189 2.2× 80 1.8× 6 0.5× 10 1.0× 24 303
Minerva Gómez Mexico 6 88 0.8× 36 0.4× 63 1.4× 14 1.3× 6 0.6× 10 197
Tatiana Sanz‐Sánchez Spain 6 50 0.4× 18 0.2× 23 0.5× 17 1.5× 6 0.6× 30 107
Maia Paul United States 7 149 1.3× 110 1.3× 64 1.4× 17 1.5× 13 1.3× 15 198
J.M. Fernández–Vozmediano Spain 9 188 1.7× 46 0.5× 34 0.8× 63 5.7× 10 1.0× 19 226
J.C. Armario-Hita Spain 11 209 1.9× 46 0.5× 47 1.0× 39 3.5× 8 0.8× 29 264
Michela Ricci Italy 7 75 0.7× 9 0.1× 13 0.3× 6 0.5× 8 0.8× 19 124
Rune Kjærsgaard Andersen Denmark 11 294 2.6× 238 2.8× 91 2.0× 5 0.5× 5 0.5× 31 315

Countries citing papers authored by Noah Goldfarb

Since Specialization
Citations

This map shows the geographic impact of Noah Goldfarb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noah Goldfarb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noah Goldfarb more than expected).

Fields of papers citing papers by Noah Goldfarb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noah Goldfarb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noah Goldfarb. The network helps show where Noah Goldfarb may publish in the future.

Co-authorship network of co-authors of Noah Goldfarb

This figure shows the co-authorship network connecting the top 25 collaborators of Noah Goldfarb. A scholar is included among the top collaborators of Noah Goldfarb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noah Goldfarb. Noah Goldfarb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Liang, Erin M. Warshaw, Amy Gravely, et al.. (2025). Variations in Anatomic Locations of Squamous Cell Carcinoma Stratified by Histologic Risk: A Single‐Center Retrospective Study. International Journal of Dermatology. 65(2). 343–346.
2.
Rizvi, M. Moshahid Alam, Liang Liu, Erin M. Warshaw, et al.. (2025). Anatomical Locations of Keratinocyte Carcinomas Among United States Veterans Affairs Healthcare System Patients in Minnesota: A Cross‐Sectional Study. Experimental Dermatology. 34(12). e70196–e70196.
3.
Theis‐Mahon, Nicole, et al.. (2024). Management of pyoderma gangrenosum during pregnancy and breastfeeding: a systematic review. International Journal of Dermatology. 64(1). 11–14.
4.
Frew, John W., Joslyn S. Kirby, Afsáneh Alavi, et al.. (2024). Discrepancies in hidradenitis suppurativa lesion characterization by providers and patients. Journal of the European Academy of Dermatology and Venereology. 39(1). 210–220. 1 indexed citations
5.
Singh, Jasvinder A., Yao Shen, Noah Goldfarb, et al.. (2024). Loss of CELF2 promotes skin tumorigenesis and increases drug resistance. International Journal of Dermatology. 64(1). 101–110. 1 indexed citations
6.
Gravely, Amy, et al.. (2024). Prevalence of abdominal aortic aneurysm in patients with hidradenitis suppurativa in the Veterans Affairs Health Care System. British Journal of Dermatology. 192(1). 160–162.
7.
Loftus, Edward V., Eric C. Ehman, Austin Todd, et al.. (2024). Differentiating clinical characteristics of perianal inflammatory bowel disease from perianal hidradenitis suppurativa. International Journal of Dermatology. 64(3). 520–530. 2 indexed citations
8.
Goldfarb, Noah, et al.. (2024). 53731 Use of generative adversarial neural networks to remove markers from skin lesion images. Journal of the American Academy of Dermatology. 91(3). AB353–AB353.
9.
Goldfarb, Noah, et al.. (2023). Treatment of pyoderma gangrenosum in pregnancy with certolizumab pegol. SHILAP Revista de lepidopterología. 3(2). 696–698. 1 indexed citations
10.
Buechler, Connor R., et al.. (2023). A case series of hydroxychloroquine exacerbating the dermatomyositis rash. Dermatology Online Journal. 29(5).
12.
Goldfarb, Noah, et al.. (2023). Angioinvasive Trichophyton rubrum associated necrotizing fasciitis in an immunocompromised patient. SHILAP Revista de lepidopterología. 11(10). e7718–e7718. 1 indexed citations
13.
Goldfarb, Noah, et al.. (2023). Skin cancer in patients treated with photobiomodulation for alopecia: a retrospective chart review. Dermatology Online Journal. 29(2).
14.
Tzellos, Thrasyvoulos, Kelsey R. van Straalen, Αthanassios Kyrgidis, et al.. (2022). Development and validation of IHS4‐55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa. Journal of the European Academy of Dermatology and Venereology. 37(2). 395–401. 30 indexed citations
15.
Freese, Rebecca, et al.. (2021). Trends in Patch Testing in the Medicare Part B Fee-for-Service Population. Dermatitis. 33(2). 129–134. 4 indexed citations
16.
Zhang, Tianshun, et al.. (2020). The effect of metformin on the risk of recurrent nonmelanoma skin cancers. International Journal of Dermatology. 59(8). e303–e305. 5 indexed citations
17.
Bonafede, Machaon, et al.. (2020). PND19 PRODUCTIVITY LOSS AMONG CAREGIVERS OF PATIENTS WITH MS. Value in Health. 23. S261–S262. 1 indexed citations
18.
Farah, Ronda S., et al.. (2020). Making the most of your mentorship: Viewpoints from a mentor and mentee,,. International Journal of Women’s Dermatology. 6(1). 63–67. 9 indexed citations
19.
Farah, Ronda S., et al.. (2018). Dermoscopy findings of a one mm lentigo maligna. Dermatology Online Journal. 24(7).
20.
Kaye, Valda N., et al.. (2012). Melanoma Tumor Seeding After Punch Biopsy. Dermatologic Surgery. 38(7). 1083–1085. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026